US Patent Issued to Dana-Farber Cancer Institute, Broad Institute on Jan. 13 for "Methods of diagnosing and treating cancer in patients having or developing resistance to a first cancer therapy" (Massachusetts Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,872, issued on Jan. 13, was assigned to Dana-Farber Cancer Institute Inc. (Boston) and Broad Institute Inc. (Cambridge, Mass.).

"Methods of diagnosing and treating cancer in patients having or developing resistance to a first cancer therapy" was invented by Levi A. Garraway (Newton, Mass.) and Cory M. Johannessen (Roslindale, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of identifying a subject having cancer who is likely to benefit from treatment with a combination therapy with a RAF inhibitor and a second inhibitor is provided. A method of treating cancer in a subject in need thereof is also provided and includes administering to ...